Minor Histocompatibility Antigen UTY as Target for Graft-versus-Leukemia and Graft-versus-Haematopoiesis in the Canine Model

Keyphrases

• Hematopoiesis 100%
• Graft-versus-leukemia Effect 100%
• Minor Histocompatibility Antigens 100%
• Canine Model 100%
• Female Dog 75%
• HLA-A2 50%
• Monocytes 50%
• Immune Response 25%
• Male Patients 25%
• B Cells 25%
• Nave 25%
• Bone Marrow Cells 25%
• Bone Marrow 25%
• Effector Lymphocytes 25%
• Antigen-specific T Cell Response 25%
• DC Cell 25%
• MHC Class II 25%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 25%
• Littermate 25%
• Stem Cell Donor 25%
• Female-to-male 25%
• Better Prognosis 25%
• Canine 25%
• Specific Reactivity 25%
• Male-specific 25%
• Dog Model 25%
• Alloimmune 25%
• PBMC Cells 25%
• In(III) 25%
• Specific T Cells 25%
• Promising Target 25%
• Derived Peptide 25%

Immunology and Microbiology

• Hematopoiesis 100%
• Canine Model 100%
• Minor Histocompatibility Antigen 100%
• Peptides 100%
• T Cell 50%
• B Cell 25%
• Bone Marrow Cell 25%
• Stem Cell 25%
• Allogeneic Stem Cell Transplantation 25%
• Immunotherapy 25%
• Lymphocyte 25%

Biochemistry, Genetics and Molecular Biology

• Hematopoiesis 100%
• Canine Model 100%
• Histocompatibility 100%
• T Cell 66%
• Stem Cell 33%
• Allogeneic Stem Cell Transplantation 33%
• B Cell 33%
• Lymphocyte 33%